نتایج جستجو برای: radioligand receptor binding assay

تعداد نتایج: 1102450  

Journal: :Molecular pharmacology 1998
F G Boess C Riemer M Bös J Bentley A Bourson A J Sleight

Ro 63-0563 [4-amino-N-(2,6 bis-methylamino-pyridin-4-yl)-benzene sulfonamide] is a high affinity 5-hydroxytryptamine6 (HT6) receptor antagonist with more than 100-fold selectivity for the 5-HT6 receptor compared with 69 other receptors and binding sites. The present study describes the properties of [3H]Ro 63-0563, the first selective 5-HT6 receptor radioligand. Specific binding of [3H]Ro 63-05...

2016
Katarina Varnäs Sjoerd J. Finnema Vladimir Stepanov Akihiro Takano Miklós Tóth Marie Svedberg Søren Møller Nielsen Nikolay A. Khanzhin Karsten Juhl Benny Bang-Andersen Christer Halldin Lars Farde

BACKGROUND Previous autoradiography studies have suggested a marked interspecies variation in the neuroanatomical localization and expression levels of the neurokinin 3 receptor, with high density in the brain of rat, gerbil, and guinea pig, but at the time offered no conclusive evidence for its presence in the human brain. Hitherto available radioligands have displayed low affinity for the hum...

Journal: :The Journal of pharmacology and experimental therapeutics 1999
Q Tang R Gandhoke A Burritt V J Hruby F Porreca J Lai

The opioid peptide dynorphin A elicits non-opioid receptor-mediated, neurotoxic response in vivo, which is blocked by pretreatment with MK-801, a noncompetitive N-methyl-D-aspartate receptor (NMDAR) antagonist. In the present study, we examined the possible direct interaction of dynorphin A on the NMDAR. A nonopioid dynorphin A analog, (125)I-(des-tyrosyl) dynorphin A(2-17), was used in radioli...

2009
Susanne Nikolaus Rolf Larisch Markus Beu Henning Vosberg Farhad Forutan Andreas Wirrwar Hans-Wilhelm Müller

In the present study, the binding potential (BP) of the D2 receptor radioligand [ 18 F]N-methyl-benperidol ([ 18 F]FMB) was determined with in vivo saturation binding analysis using either cerebellum or parietal cortex as reference region. For the purpose of validation, BP additionally was determined in the same set of animals by computing the equilibrium ratios of the distribution volumes (V3’...

Journal: :Hypertension 1998
G Nickenig K Strehlow J Roeling O Zolk A Knorr M Böhm

The molecular events governing salt-sensitive hypertension are currently unknown. Because the renin-angiotensin system plays a central role in blood pressure regulation, as well as electrolyte balance, it may be closely involved in the phenomenon of salt sensitivity. Therefore, we examined the effect of a high salt diet (8%) on aortic angiotensin type 1 (AT1) receptor expression in Sprague-Dawl...

Journal: :Japanese journal of pharmacology 1993
S Shima

Characterization of adrenergic receptors in membranes from the rat seminal vesicle was studied by radioligand binding assay. Seminal vesicle membranes contained saturable and high affinity binding sites for the beta-adrenergic receptor antagonist 3H-dihydroalprenolol (3H-DHA) and for the alpha-adrenergic antagonist 3H-prazosin. The observed order of potency for adrenergic agonists in competing ...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
G Patrick Hussmann Kenneth J Kellar

We have developed a new radioligand binding assay method to measure the concentration of nonradiolabeled drugs in the brain ex vivo. This new method fuses the concepts of standard competition and saturation binding assays and uses a transformed version of the Cheng-Prusoff equation (Biochem Pharmacol 22:3099-3108, 1973) to calculate the drug concentration. After testing the validity of this met...

2016
Claire L Newton Martyn D Wood Philip G Strange

Many G protein-coupled receptors have been shown to be sensitive to the presence of sodium ions (Na+). Using radioligand competition binding assays, we have examined and compared the effects of sodium ions on the binding affinities of a number of structurally diverse ligands at human dopamine D2 and dopamine D3 receptor subtypes, which are important therapeutic targets for the treatment of psyc...

Journal: :The Journal of pharmacology and experimental therapeutics 2004
Susan K Sullivan Robert E Petroski Gail Verge Raymond S Gross Alan C Foster Dimitri E Grigoriadis

Clinically used benzodiazepine and nonbenzodiazepine sedative-hypnotic agents for the treatment of insomnia produce their therapeutic effects through allosteric enhancement of the effects of the inhibitory neurotransmitter GABA at the GABA(A) receptor. Indiplon is a novel pyrazolopyrimidine sedative-hypnotic agent, currently in development for insomnia. Using radioligand binding studies, indipl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید